Projected Income Statement: MPLX LP

Forecast Balance Sheet: MPLX LP

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 20,124 18,558 19,558 19,383 19,429 22,820 24,001 24,348
Change - -7.78% 5.39% -0.89% 0.24% 17.45% 5.18% 1.45%
Announcement Date 02/02/21 02/02/22 31/01/23 30/01/24 04/02/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: MPLX LP

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 993 596 806 937 1,056 1,570 2,376 1,635
Change - -39.98% 35.23% 16.25% 12.7% 48.69% 51.33% -31.19%
Free Cash Flow (FCF) 1 3,528 4,399 4,213 4,135 3,942 3,101 3,827 4,649
Change - 24.69% -4.23% -1.85% -4.67% -21.34% 23.42% 21.49%
Announcement Date 02/02/21 02/02/22 31/01/23 30/01/24 04/02/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: MPLX LP

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 68.85% 55.45% 49.73% 55.57% 56.68% 54.45% 55.51% 55.89%
EBIT Margin (%) 2.79% 39.81% 42.29% 43.44% 44.31% 45.29% 43.15% 43.61%
EBT Margin (%) -9.05% 31.05% 34.32% 35.25% 36.6% 37.23% 34.72% 35.85%
Net margin (%) -11.12% 29.28% 32.85% 33.94% 35.95% 36.43% 34.99% 35.57%
FCF margin (%) 46.61% 43.87% 36.28% 36.65% 33.03% 24.04% 28.58% 32.7%
FCF / Net Income (%) -419% 149.83% 110.43% 107.99% 91.89% 65.99% 81.68% 91.93%

Profitability

        
ROA -2.19% 8.16% 10.72% 10.61% 11.59% 11.1% 11.3% 11.7%
ROE -5.68% 23.89% 27.15% 29.75% 32.96% 33.22% 33.03% 35.12%

Financial Health

        
Leverage (Debt/EBITDA) 3.86x 3.34x 3.39x 3.09x 2.87x 3.25x 3.23x 3.06x
Debt / Free cash flow 5.7x 4.22x 4.64x 4.69x 4.93x 7.36x 6.27x 5.24x

Capital Intensity

        
CAPEX / Current Assets (%) 13.12% 5.94% 6.94% 8.31% 8.85% 12.17% 17.75% 11.5%
CAPEX / EBITDA (%) 19.06% 10.72% 13.96% 14.95% 15.61% 22.35% 31.97% 20.58%
CAPEX / FCF (%) 28.15% 13.55% 19.13% 22.66% 26.79% 50.64% 62.09% 35.17%

Items per share

        
Cash flow per share 1 4.302 4.782 4.969 5.386 5.847 6.827 5.69 -
Change - 11.16% 3.92% 8.39% 8.55% 16.77% -16.66% -
Dividend per Share 1 2.75 3.36 2.96 3.25 3.613 4.049 4.505 5.035
Change - 22.18% -11.9% 9.8% 11.17% 12.07% 11.26% 11.78%
Book Value Per Share 1 12.39 11.5 12.31 12.66 13.35 14.17 14.47 14.36
Change - -7.14% 7.06% 2.86% 5.4% 6.2% 2.11% -0.78%
EPS 1 -0.8 2.86 3.75 3.8 4.21 4.707 4.519 4.942
Change - 457.5% 31.12% 1.33% 10.79% 11.81% -4% 9.35%
Nbr of stocks (in thousands) 10,40,169 10,19,864 10,03,243 10,01,217 10,18,812 10,17,065 10,17,065 10,17,065
Announcement Date 02/02/21 02/02/22 31/01/23 30/01/24 04/02/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio 11.4x 11.9x
PBR 3.8x 3.72x
EV / Sales 6.01x 5.88x
Yield 7.52% 8.37%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
53.84USD
Average target price
57.23USD
Spread / Average Target
+6.30%
Consensus

Quarterly revenue - Rate of surprise